ADVOCATE LUTHERAN GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1897-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Toremifene in Treating Patients With Desmoid Tumors
Phase 2
Completed
- Conditions
- Desmoid Tumor
- First Posted Date
- 2004-04-22
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- Advocate Lutheran General Hospital
- Target Recruit Count
- 72
- Registration Number
- NCT00002595
- Locations
- 🇺🇸
Lutheran General Hospital, Park Ridge, Illinois, United States
Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer
Phase 1
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- Advocate Lutheran General Hospital
- Registration Number
- NCT00020644
- Locations
- 🇺🇸
Lutheran General Cancer Care Center, Park Ridge, Illinois, United States
News
No news found